Skip to main content

Research Repository

Advanced Search

All Outputs (90)

Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS) (2018)
Journal Article

© 2018 The Author(s). Background: Nocturia is a common urinary symptom of multiple sclerosis (MS) which can affect quality of life (QoL) adversely. Melatonin is a hormone known to regulate circadian rhythm and reduce smooth muscle activity such as in... Read More about Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).

Development and psychometric evaluation of ICIQ-PadPROM: A quality of life questionnaire to assess the treatment effect of absorbent continence products (2018)
Journal Article

© 2018 Wiley Periodicals, Inc. Aim: To describe the development and evaluation of the ICIQ-PadPROM, the first self-reported quality of life questionnaire to assess the treatment effect of absorbent continence products, a new addition to the set of IC... Read More about Development and psychometric evaluation of ICIQ-PadPROM: A quality of life questionnaire to assess the treatment effect of absorbent continence products.

Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): Study protocol for a randomised controlled trial (2018)
Journal Article

© 2018 The Author(s). Background: Stress urinary incontinence (SUI) is a frequent adverse effect for men undergoing prostate surgery. A large proportion (around 8% after radical prostatectomy and 2% after transurethral resection of prostate (TURP)) a... Read More about Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): Study protocol for a randomised controlled trial.

Participant’s experiences of taking melatonin for the treatment of nocturia in MS: Qualitative findings from a double blind RCT (2017)
Presentation / Conference Contribution

Multiple Sclerosis (MS) is a chronic neurological disorder caused by eventual neurodegeneration within the central nervous system resulting in impaired physical, cognitive and psychological functioning. It is often progressive and can result in many... Read More about Participant’s experiences of taking melatonin for the treatment of nocturia in MS: Qualitative findings from a double blind RCT.

Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013 (2017)
Journal Article

© 2017 Wiley Periodicals, Inc. Background: Evidence-based guidelines for the management of neurological disease and lower bowel dysfunction have been produced by the International Consultations on Incontinence (ICI). These are comprehensive guideline... Read More about Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013.

Adapting the QuinteT Recruitment Intervention (QRI) to optimise recruitment in an ongoing randomised controlled trial (2017)
Presentation / Conference Contribution

Randomised Controlled Trials (RCTs) are the most rigorous study design to evaluate healthcare interventions. However, their success relies on patient recruitment. The QuinteT Recruitment Intervention (QRI) aims to address recruitment difficulties an... Read More about Adapting the QuinteT Recruitment Intervention (QRI) to optimise recruitment in an ongoing randomised controlled trial.

Can a patient reported outcome be adequate without assessing quality of life in lower urinary tract dysfunction? (2017)
Journal Article

© 2017 Wiley Periodicals, Inc. AIMS AND METHODS: A think tank was convened at the sixth ICI-RS meeting held in the United Kingdom on September 2015, to consider the adequacy of patient reported outcome (PRO) measurement if quality of life (QoL) evalu... Read More about Can a patient reported outcome be adequate without assessing quality of life in lower urinary tract dysfunction?.

Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS) (2017)
Journal Article

© 2017 The Author(s). Background: Nocturia (the symptom of needing to wake up to pass urine) is common in progressive Multiple Sclerosis (MS) patients. Moderate-to-severe nocturia affects quality of life, can exacerbate fatigue and may affect capacit... Read More about Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS).

Bladder diary and symptom scores (2016)
Book Chapter

A summary of the use of bladder diaries and symptom scores for the evaluation of lower urinary tract symptoms.

Validated constipation symptom and quality-of-life measures neither reflect patient and clinician concerns nor use words familiar to patients (2016)
Journal Article

© MA Healthcare Ltd. Patients' self-reported constipation symptoms, preferred terminology and quality of life (QoL) issues were explored through 14 semi-structured and five unstructured interviews. In a modified Delphi study, 11 clinicians rated the... Read More about Validated constipation symptom and quality-of-life measures neither reflect patient and clinician concerns nor use words familiar to patients.